According to IMARC Group’s latest report, titled “Drug Discovery Informatics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027”, the global drug discovery informatics market reached a value of US$ 2.7 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 5.1 Billion by 2027, exhibiting a CAGR of 11.62% during 2022-2027.
Drug discovery informatics (DDI) is a technical solution utilized for discovering new treatments and developing effective medications through comprehensive research and screenings. It uses sophisticated bioinformatics algorithms to process biomechanical data related to drugs, proteins, diseases, pathways, gene expression, and sequence data. It also encompasses various hardware and software-based solutions for protecting databases and researching, docking, interpreting, visualizing, and preparing drug formulations cost-effectively. Besides this, DDI analyses new drug entities, handles biological information from multiple sources, and performs several pharmacovigilance tasks and clinical decisions post trials.
COVID-19 Impact Analysis:
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Request a Free PDF Sample of the Report: https://www.imarcgroup.com/drug-discovery-informatics-market/requestsample
Market Trends and Drivers:
The increasing prevalence of various chronic disorders, especially amongst the geriatric population, and the growing need for effective medicines at affordable prices are driving the drug discovery informatics market growth. Additionally, the outbreak of the coronavirus disease (COVID-19) pandemic has prompted governments to invest in the pharmaceutical industry to formulate vaccines, which, in turn, is augmenting the product demand. Apart from this, substantial improvements in the healthcare infrastructure, the advent of in-silico tools and physiologically based pharmacokinetic (PBK) simulator to select pediatric doses, and ongoing research and development (R&D) activities to enhance the drug discovery informatics efficacy are supporting the market growth.
Drug Discovery Informatics Market 2022-2027 Competitive Analysis and Segmentation:
Competitive Landscape With Key Players:
The competitive landscape of the drug discovery informatics market has been studied in the report with the detailed profiles of the key players operating in the market.
Some of these key players include:
Accenture PlcCertaraCharles River Laboratories Inc.Collaborative Drug Discovery Inc.Eurofins DiscoverX ProductsInfosys Ltd.International Business Machines CorporationJubilant Biosys LimitedOracle CorporationPerkinElmer Inc.SelvitaThermo Fisher Scientific Inc.Key Market Segmentation:
The report has segmented the global drug discovery informatics market on the basis of workflow, function, mode, end user and region.
Breakup by Workflow:
Drug DiscoveryDrug DevelopmentBreakup by Function:
Sequence Analysis PlatformsMolecular ModelingMolecular DockingClinical Trial Data ManagementOthersBreakup by Mode:
OutsourcedIn-houseBreakup by End User:
Pharmaceutical CompaniesBiotechnology CompaniesContract Research Organization (CROs)OthersBreakup by Region:
North AmericaAsia-PacificEuropeLatin AmericaMiddle East and AfricaAsk Analyst for Customization and Explore Full Report With TOC & List of Figures: https://www.imarcgroup.com/request?type=report&id=3515&flag=C
Key Highlights of the Report:
Market Performance (2016-2021)Market Outlook (2022-2027)Market TrendsMarket Drivers and Success FactorsImpact of COVID-19Value Chain AnalysisComprehensive mapping of the competitive landscapeIf you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Email: [email protected]
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800
Sign in to leave a comment.